One assignee leads clearly with 98 of the 898 records in scope, built around gas-fermentation bioreactor design and control. The top 5 assignees combined hold 301 records, or 33.5% of the field, after which filing volume drops off quickly into a long tail of companies with only a handful of filings each. This pattern points to a field with a dominant early mover but plenty of room for new entrants to stake claims outside its core hardware.

Complete-year data shows growth: filings rose from 29 in 2021 to 39 in 2024, a 34% increase over that span, after an earlier peak of 62 in 2019. The apparent decline in 2025 and 2026 is a publication-lag artefact — patents typically publish about 18 months after filing, so the most recent one to two years always look understated. Treat 2024 as the last reliable complete year for trend reading.

Bioreactor and apparatus design (IPC class C12M) covers 72.9% of the 898 records, the largest share by a wide margin, followed by fermentation and enzymatic synthesis process claims (C12P) at 58.7% and microorganism/genetic engineering claims (C12N) at 39.9%. Smaller but present branches include food applications, peptide/protein claims, separation processes, and medicinal preparation uses — each in the 6-8% range. This tells you claim activity is weighted toward the physical reactor and gas-delivery hardware more than the downstream biological process.

US11884909B2 claims a cluster airlift bioreactor with multiple spargers arranged across several independent vertical circulation loops, each with its own mass transfer coefficient, coordinated by a controller to keep the cumulative transfer coefficient within a target range. It specifically blocks designs that combine multiple independently-sparged circulation loops under unified cumulative kLa control. Designs using a single mixing volume, a different sparger coordination scheme, or control targeting individual rather than cumulative loop performance would sit outside its literal claim scope, though a full freedom-to-operate review should check the dependent claims too.

The composition data shows real-time dissolved-oxygen sensing tied directly to control loops, micro-bubble sparger geometry, and multi-loop reactor coordination sit below the dominant C12M and C12P claim volumes, suggesting lighter filing density there relative to core bioreactor and fermentation process claims. Separation-integrated bioreactor design, where filtration or downstream separation is built into the oxygen-transfer vessel itself, is another area with comparatively few dedicated filings. These are starting points for a novelty search, not guarantees of open claim space, since density is not the same as vacancy.